News
Scientific discussion of the laboratory, every wednesday from 15:00 pm to 16:00 pm. For more information and how to attend please contact:
Lecture series of GRK
https://www.uni-due.de/grk2989/lectures.php
Publications
Latest Publications
Hendgen-Cotta UB, Roth A, Beuck C, Messiha D, Settelmeier S, Shah SB, Korste S, Bravo-Rodriguez K, Blueggel M, Cansiz F, Martins Nascentes Melo L, Roesler J, Meckelmann SW, Schmitz OJ, Kaschani F, Kaiser M, Esfeld S, El Bounkari O, Bernhagen J, Brameyer S, Jung K, Schmitt LI, Leo M, Hagenacker T, Totzeck M, Minor T, Ehrmann M, Tasdogan A, Bayer P, Rassaf T. Reverse engineering of BNIP3 identifies a mitochondrial protective peptide. Nat Commun. 2026; 17(1):5359. doi: 10.1038/s41467-026-73993-2.
Settelmeier S, Agranovski D, Steinhardt M, Waydhas S, Gering I, Cejka V, Morbach C, Störk S, Willbold D, Küppers R, Vogel J, Michel L, Carpinteiro A, Reinhardt HC, Dodel R, Rassaf T, Ross AJ, Hendgen-Cotta UB. Transthyretin stabilizer therapy increases naturally-occurring antibodies in ATTR cardiomyopathy. Amyloid. 2026:1-17. doi: 10.1080/13506129.2026.2651299.
Settelmeier S, Kessler L, Hammersen N, Papathanasiou M, Rischpler C, Carpinteiro A, Oubari S, Michel L, Vogel J, Wollenweber T, Ning J, Hacker M, Spielvogel CP, Varasteh Z, Fendler WP, Barbato F, Costa PF, Leyser S, Rassaf T, Herrmann K, Telli T, Kersting D. Early timepoint 99mTc-DPD whole body scintigraphy and quantitative SPECT/CT imaging for diagnosis of cardiac ATTR amyloidosis. EJNMMI Res. 2026; 16(1):92. doi: 10.1186/s13550-026-01466-0.
Salhöfer, L., Hendgen-Cotta, U. B., Fandrey, J., Schreiber, T., & Leu, T. (2026). Cardioprotective effects of prolyl hydroxylase inhibitors during reperfusion in myocardial infarction: A study using cardiosphere-derived cells. Experimental Physiology, 1–15. https://doi.org/10.1113/EP093391